Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment-Reference-Cited by-同舟云学术

Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment

Published:2006-08-01 Issue:2 Volume:166 Page:131-137
ISSN:0340-6199
Container-title:European Journal of Pediatrics
language:en
Short-container-title:Eur J Pediatr

Author:

Sano Tetsuya,Kurotobi Shunji,Matsuzaki Kouji,Yamamoto Takehisa,Maki Ichiro,Miki Kazunori,Kogaki Shigetoyo,Hara Junichi

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00431-006-0223-z.pdf

Reference30 articles.

1. Ahn SY, Kim DS (2005) Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate. Scand J Rheumatol 34(2):136–139

2. Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME (2005) Infliximab treatment for refractory Kawasaki syndrome. J Pediat 146(5):662–667

3. Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK (2004) Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol 43(1):120–124

4. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW (1998) Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 133(2):254–258

5. Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, Dillon MJ, Deanfield JE (1996) Endothelial dysfunction late after Kawasaki disease. Circulation 94(9):2103–2106

Cited by 316 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Risk-Scoring Systems in Predicting Kawasaki Disease Associated Coronary Artery Dilation in a North American Cohort;Pediatric Cardiology;2024-08-04

2. Construction and validation of predictive models for intravenous immunoglobulin–resistant Kawasaki disease using an interpretable machine learning approach;Clinical and Experimental Pediatrics;2024-07-23

3. Establishment and validation of a nomogram for predicting intravenous immunoglobulin resistance and coronary artery lesions involvement in Kawasaki disease: A retrospective study;2024-07-19

4. Candesartan Attenuates Vasculitis in a Mouse Model of Kawasaki Disease Induced by <i>Candida albicans</i> Water-Soluble Fraction;Journal of Nippon Medical School;2024-06-25

5. Platelets in Kawasaki disease: mediators of vascular inflammation;Nature Reviews Rheumatology;2024-06-17